Alexza Pharmaceuticals, Inc. Stock Nasdaq
Equities
US0153841004
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Managers | Title | Age | Since |
---|---|---|---|
Stacy Palermini
DFI | Director of Finance/CFO | - | 02-12-31 |
Tatjana Naranda
PSD | President | - | 04-12-31 |
Wolfgang Schmidt
PRN | Corporate Officer/Principal | - | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 16-06-20 | |
Director/Board Member | - | 16-06-20 | |
Director/Board Member | - | 16-06-20 |
1st Jan change | Capi. | |
---|---|---|
+15.58% | 121B | |
+16.60% | 110B | |
+17.73% | 25.93B | |
-24.33% | 19.27B | |
-19.35% | 16.01B | |
-17.95% | 15.66B | |
-48.32% | 14.89B | |
+58.78% | 14.47B | |
+4.91% | 13.91B |
- Stock Market
- Equities
- Stock
- Stock